Improved Clinical and Microscopy Diagnosis at Primary Health Care in Tanzania

Quality Malaria Case Management In Under- Fives In Primary Health Care (Phc) Institutions In Bagamoyo And Kibaha Districts Of Coastal Tanzania:a Multicomponent Controlled Intervention Study

General objective: To improve the quality of fever case management in children in government health facilities in Tanzania Hypothesis:The training of health workers, as well as provision, training and use of microscopes for malaria diagnosis will improve the treatment of clinical episodes of fever in children while reducing the amount and costs of drugs

Study Overview

Status

Completed

Conditions

Detailed Description

PHC facilities were eligible for the study if they were rural government owned; accessible by road during rainy season; and within 3 hours by car from Muhimbili University College of Health Sciences (MUCHS), Dar es Salaam

All children attending the 16 PHC facilities under the study during daytime were enrolled if they fulfilled the following criteria:

  1. below five years of age
  2. fever (temperature≥37.5◦C) and/or reported history of fever in last 2 days
  3. able to return to the facility on day 7 after treatment or any other day if symptoms were to worsen or recur
  4. the mother/guardian or caretaker consented to participate.

Patients with severe disease and/or general danger signs requiring inpatient care according to the IMCI guidelines were admitted or referred to the health centers or the district hospitals

Study Type

Interventional

Enrollment (Actual)

3131

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Coast, Tanzania
        • dispensaries/health centers in Kibaha and Bagamoyo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 months to 4 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. below five years of age
  2. fever (temperature≥37.5◦C) and/or reported history of fever in last 2 days
  3. able to return to the facility on day 7 after treatment or any other day if symptoms were to worsen or recur
  4. the mother/guardian or caretaker consented to participate

Exclusion Criteria:

a) N/A

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: 3
Control
Experimental: 1
training in clinical algorithm plus microscopy

Clinical alogarithm

The content of the package included

  1. description of signs and symptoms of malaria disease
  2. history taking relevant to malaria and physical examination
  3. identification of danger signs and severe illness for referral
  4. appropriate treatment
  5. counseling patients on the use of drugs.

Malaria microscopy. contents

  1. make thick blood smears from patients with fever and stain with Giemsa
  2. identify and count malaria parasites
  3. maintain the microscope and store blood slides.
Experimental: 2
clinical algorithm

Clinical alogarithm

The content of the package included

  1. description of signs and symptoms of malaria disease
  2. history taking relevant to malaria and physical examination
  3. identification of danger signs and severe illness for referral
  4. appropriate treatment
  5. counseling patients on the use of drugs.

Malaria microscopy. contents

  1. make thick blood smears from patients with fever and stain with Giemsa
  2. identify and count malaria parasites
  3. maintain the microscope and store blood slides.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
the proportion of study children receiving prescriptions of antimalarial drugs in the respective arms
Time Frame: Day 0
Day 0

Secondary Outcome Measures

Outcome Measure
Time Frame
prescriptions of antibiotics, cost of drugs
Time Frame: Day 0
Day 0
health outcome of the patients
Time Frame: Day 1-6, day 7
Day 1-6, day 7

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Anders Bjorkman, MD, Karolinska Institutet

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2003

Primary Completion (Actual)

March 1, 2004

Study Completion (Actual)

March 1, 2004

Study Registration Dates

First Submitted

May 28, 2008

First Submitted That Met QC Criteria

May 28, 2008

First Posted (Estimate)

June 2, 2008

Study Record Updates

Last Update Posted (Estimate)

June 2, 2008

Last Update Submitted That Met QC Criteria

May 28, 2008

Last Verified

May 1, 2008

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Malaria

Clinical Trials on Clinical algorithm and microscopy diagnosis of malaria

3
Subscribe